Jianlong Wang

Jianlong Wang is a Professor of Medical Sciences (in Medicine) at Columbia University Irving Medical Center, where he joined in 2019, and a member of the Tumor Biology and Microenvironment program at the Herbert Irving Comprehensive Cancer Center; he is listed among the pulmonary division's research faculty but is a basic stem-cell biologist rather than a clinician. He earned a PhD in biochemistry and molecular biology from the University of Massachusetts Amherst and the Institute of Microbiology of the Chinese Academy of Sciences and holds an MS in molecular virology. His lab studies how pluripotency and totipotency are established and maintained, focusing on Tet1/Tet2, Zfp281/ZNF281, ribosome heterogeneity and translational control, with senior-author papers in Nature Genetics, Cell Stem Cell, PNAS and Science Advances, and extends this to leukemogenesis and breast-cancer dormancy. He is funded by multiple NICHD R01s and an R21 (totipotency, TET2 chromatin targeting, nucleolar control of pluripotency, NSUN2), and previously held the Harvard Stem Cell Institute Cell Development Award (2007), the Lamport Research Award (2013) and an Irma T. Hirschl/Weill-Caulier Career Scientist Award (2013–2017).